Phenyl salicylate

Phenyl salicylate
  • CAS No.:118-55-8
Other grades of this product :
Phenyl salicylate Basic information
Description References
Product Name:Phenyl salicylate
Synonyms:Phenyl 2-hydroxybenzoate(Phenyl salicylate);Phenyl salicy;Phenyl salicylate,Salol;Phenyl Salicylate, crystal;Phenyl Salicylate Melting Point Standard (500 mg) (Approximately 41 degrees);Phenyl salicylate, 99% 250GR;2-Hydroxybenzoic Acid Phenyl Ester Phenyl 2-Hydroxybenzoate Salicylic Acid Phenyl Ester;Salicylic acid phenyl
CAS:118-55-8
MF:C13H10O3
MW:214.22
EINECS:204-259-2
Product Categories:Building Blocks;C12 to C63;Carbonyl Compounds;Chemical Synthesis;Esters;Liquid Crystals;Aromatic Esters;Functional Materials;Liquid Crystals & Related Compounds;Phenyl Esters (Liquid Crystals);Materials Science;Organic and Printed Electronics;Organic Building Blocks
Mol File:118-55-8.mol
Phenyl salicylate Chemical Properties
Melting point 41-43 °C (lit.)
Boiling point 172-173 °C/12 mmHg (lit.)
density 1.250g/cm3
refractive index 1.5090 (estimate)
FEMA 3960 | PHENYL SALICYLATE
Fp >230 °F
storage temp. 2-8°C
solubility dioxane: 0.1 g/mL, clear, colorless
form Fine Crystalline Powder
pka8.71±0.10(Predicted)
color White
Water Solubility Soluble in alcohol, ether, chloroform, turpentine, acetone and benzene. Sparingly soluble in chloroformbenzene. Insoluble in water.
Merck 14,7310
JECFA Number736
BRN 393969
Stability:Light sensitive. Incompatible with strong oxidants. Flammable.
CAS DataBase Reference118-55-8(CAS DataBase Reference)
NIST Chemistry ReferenceBenzoic acid, 2-hydroxy-, phenyl ester(118-55-8)
EPA Substance Registry SystemPhenyl salicylate (118-55-8)
Safety Information
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36-24/25
RIDADR UN 3077 9 / PGIII
WGK Germany 2
RTECS VO6125000
TSCA Yes
HS Code 29182300
MSDS Information
ProviderLanguage
Disperse Dye Blue EXSF English
ACROS English
SigmaAldrich English
ALFA English
Phenyl salicylate Usage And Synthesis
DescriptionPhenyl salicylate (chemical formula: C13H10O3) belongs to the family of hydroxybenzoic acid which are compound containing a hydroxybenzoic acid or its derivative. It is manufactured through the chemical reaction between phenol and salicylic acid. Phenyl salicylate has several medical properties. It can be used as analgesic to relieve pain, as an antiseptic with antibacterial effect as well as a kind of antipyretic for the treatment of fever. It is also used for the treatment of inflammation triggered by the lower urinary tract. However, it is no longer commonly applied to human medicine, but is still used in veterinary medicine.
Referenceshttps://pubchem.ncbi.nlm.nih.gov/compound/Phenyl_salicylate#section=Top http://www.wisegeek.com/what-are-the-medical-uses-of-phenyl-salicylate.htm
Chemical PropertiesPhenyl salicylate is a white crystalline solid with a distinctive aromatic odor and taste. Soluble in ether, benzene and chloroform, soluble in ethanol, almost insoluble in water and glycerol.
UsesPhenyl salicylate is used as an analgesic and antipyretic. It is also used in the manufacture of polymer plastics, lacquers, waxes, polishes, adhesives, and sunscreen products(suntan oils and cremes). As light absorber to prevent discoloration of plastics. It is also a fragrance ingredient, but has limited use. in veterinary use as an external disinfectant and intestinal antiseptic agent.
DefinitionChEBI: Phenyl salicylate is a benzoate ester that is the phenyl ester of salicylic acid. Also known as salol, it can be formed by heating salicylic acid with phenol and is used in the manufacture of some polymers, lacquers, adhesives, waxes and polishes. It has a role as an ultraviolet filter. It is a benzoate ester, a member of phenols and a member of salicylates. It derives from a salicylic acid.
PreparationPhenyl salicylate was synthesized by esterification of salicylic acid and phenol in the presence of catalyst sulfuric acid. The esterification liquid is neutralized, washed with water and distilled to obtain the finished product. It also can preparation by the action of phosphorus oxychloride on a mixture of phenol and salicylic acid (Merck Index, 1968).
Toxicity evaluationThe acute oral LD50 value in rats was reported as 3 g/kg and the acute dermal LD50 value in rabbits exceeded 5 g/kg (Levenstein, 1975). The probable LD in man is 50-500 mg/kg. The toxic effects of phenyl salicylate are similar to those of phenol but do not include a corrosive action on the alimentary canal (Dittmer, 1959).
General DescriptionWhite crystals. Insoluble in water.
Air & Water ReactionsInsoluble in water.
Reactivity ProfileIncompatible with bromine water, ferric salts, camphor, phenol, chloral hydrate, monobrominated camphor, thymol, or urethane in trituration. .
Fire HazardFlash point data for Phenyl salicylate are not available, however Phenyl salicylate is probably combustible.
PharmacologyPhenyl salicylate was found to have slight analgesic activity against pain stimuli in mice (Kameyama, 1961), but ip administration of 500 mg/kg showed no analgesic action against an electric shock applied to the tails of mice (McKenzie & Beechey, 1962). In vitro studies on cartilage and rat-liver mitochondria have shown that phenyl salicylates are more active than salicylates in uncoupling oxidative phosphorylation (Bostrom, Berntsen & Whitehouse, 1964).
Safety ProfileModerately toxic by ingestion. Experimental teratogenic and reproductive effects. When heated to decomposition it emits acrid smoke and irritating fumes. See also ESTERS
MetabolismAccording to Baas (1890) from 44 to 96% of a dose (5-8 g) of phenyl salicylate is hydrolysed in man and none of it is found in the faeces. An increase in the ethereal sulphates of the urine after its ingestion is due, no doubt, to the phenol liberated (Williams, 1959). Phenyl salicylate is hydrolysed in the gut primarily to phenol and salicylic acid, which are rapidly absorbed and excreted (Fassett, 1963), but it was not hydrolysed by a partially purified preparation of acetylarylesterase from human plasma (Augustinsson & Ekedahl, 1962). Intestinal absorption and excretion of orally administered phenyl salicylate were studied in rabbits and dogs by analysis of blood and urine samples; oral administration of glucosamine hydrochloride increased the blood concentration of phenyl salicylate but had little effect on urinary excretion (Tanaka, Kojima & Matsubara, 1961).
Purification MethodsFractionally crystallise salol from its melt, then crystallise it from *benzene. [Beilstein 10 IV 154.]

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye